Case Based Peer Perspectives

Case-Based Peer Perspectives

Targeted Oncology presents Case-Based Peer Perspectives. In each video, expert physicians provide insight on managing oncology-based patient cases that highlight the use of novel agents in clinical practice.


A 76-Year-Old Man with Relapsed DLBCL

July 23rd 2021

Laurie Sehn, MD, presents the case of a 76-year-old man with relapsed diffuse B-cell lymphoma and highlights the treatment options available to patients.

Expert Perspectives on a 77-Year-Old Man With Relapsed Chronic Lymphocytic Leukemia

July 16th 2021

Andrew Zelenetz, MD, reviews the diagnosis and treatment plan for a 77-year-old man with relapsed chronic lymphocytic leukemia (CLL) while highlighting several treatment options.

A 73-Year-Old Woman With Chronic Lymphocytic Leukemia

June 24th 2021

An expert in hematology oncology, Jeff Sharman, MD, reviews the case of a 73-year-old woman with chronic lymphocytic leukemia (CLL) and shares key insights into factors to consider when selecting first- and second-line treatment.

A 68-Year-Old Man With Hepatocellular Carcinoma

June 23rd 2021

Ghassan K. Abou-Alfa, MD, MBA, reviews key clinical trial data and treatment options for the management of unresectable HCC.

A 59-Year-Old Man With Extensive-Stage Small Cell Lung Cancer

June 21st 2021

Thought leader in thoracic oncology, Hossein Borghaei, DO, reviews the case of a 59-year-old man with extensive-stage small-cell lung cancer and discusses the current treatment landscape by highlighting key clinical trial data on the safety and efficacy of lurbinectedin.

Expert Perspectives on a 75-Year-Old Woman With Relapsed/Refractory Follicular Lymphoma

May 20th 2021

Loretta Nastoupil, MD, provides insights into the contemporary and future treatment options for a patient with relapsed/refractory follicular lymphoma (R/R FL).

A 64-Year-Old Woman With Extensive-Stage Small Cell Lung Cancer

May 18th 2021

Thought leader in thoracic oncology, Jared Weiss, MD, reviews the case of a 64-year-old woman with extensive-stage small-cell lung cancer and discusses the current treatment landscape by highlighting key clinical trial data on the safety and efficacy of lurbinectedin.

Expert Perspectives of a 67-Year-Old Man with Metastatic HER2+ Gastric Cancer

May 5th 2021

John Marshall, MD, reviews the case of a patient with metastatic HER2+ (human epidermal growth factor receptor 2) cancer of the gastroesophageal junction.

Expert Perspectives on a 76-Year-Old Man with Relapsed DLBCL

May 3rd 2021

John Burke, MD, reviews the case of a 76-year-old man with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) while analyzing current and future treatment options in R/R DLBCL.

A 67-Year-Old Woman With Ovarian Cancer

April 27th 2021

Chirag Shah, MD, MPH, an expert in gynecologic oncology, reviews the case of a 67-year-old woman with ovarian cancer and discusses factors to consider when selecting therapy including the recent results of the PRIMA and NOVA trials of niraparib in patients with ovarian cancer.